Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models.
Gigler G, Móricz K, Agoston M, Simó A, Albert M, Benedek A, Kapus G, Kertész S, Vegh M, Barkóczy J, Markó B, Szabó G, Matucz E, Gacsályi I, Lévay G, Hársing LG Jr, Szénási G. Gigler G, et al. Among authors: kertesz s. Br J Pharmacol. 2007 Sep;152(1):151-60. doi: 10.1038/sj.bjp.0707362. Epub 2007 Jul 2. Br J Pharmacol. 2007. PMID: 17603549 Free PMC article.
A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential.
Ling I, Mihalik B, Etherington LA, Kapus G, Pálvölgyi A, Gigler G, Kertész S, Gaál A, Pallagi K, Kiricsi P, Szabó É, Szénási G, Papp L, Hársing LG, Lévay G, Spedding M, Lambert JJ, Belelli D, Barkóczy J, Volk B, Simig G, Gacsályi I, Antoni FA. Ling I, et al. Among authors: kertesz s. Eur J Pharmacol. 2015 Oct 5;764:497-507. doi: 10.1016/j.ejphar.2015.07.005. Epub 2015 Jul 11. Eur J Pharmacol. 2015. PMID: 26169564
Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.
Gacsályi I, Nagy K, Pallagi K, Lévay G, Hársing LG Jr, Móricz K, Kertész S, Varga P, Haller J, Gigler G, Szénási G, Barkóczy J, Bíró J, Spedding M, Antoni FA. Gacsályi I, et al. Among authors: kertesz s. Neuropharmacology. 2013 Jan;64:254-63. doi: 10.1016/j.neuropharm.2012.07.017. Epub 2012 Jul 21. Neuropharmacology. 2013. PMID: 22824189
2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects.
Szénási G, Vegh M, Szabo G, Kertesz S, Kapus G, Albert M, Greff Z, Ling I, Barkoczy J, Simig G, Spedding M, Harsing LG Jr. Szénási G, et al. Among authors: kertesz s. Neurochem Int. 2008 Jan;52(1-2):166-83. doi: 10.1016/j.neuint.2007.07.002. Epub 2007 Jul 10. Neurochem Int. 2008. PMID: 17707550 Review.
Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent.
Etherington LA, Mihalik B, Pálvölgyi A, Ling I, Pallagi K, Kertész S, Varga P, Gunn BG, Brown AR, Livesey MR, Monteiro O, Belelli D, Barkóczy J, Spedding M, Gacsályi I, Antoni FA, Lambert JJ. Etherington LA, et al. Among authors: kertesz s. Neuropharmacology. 2017 Oct;125:353-364. doi: 10.1016/j.neuropharm.2017.08.012. Epub 2017 Aug 12. Neuropharmacology. 2017. PMID: 28807671
148 results